New majority shareholder at Dr. Martens
The British footwear company has announced that the Guernsey-based IngreGrsy has acquired a 38.46% stake in the brand as part of a restructuring within owner Permira’s buyout fund
As such, IngreGrsy replaced Luxembourg-based IngreLux as the majority shareholder in Permira V, the global private equity fund under British global investment firm Permira.
In the statement, the company noted that Permira V Fund’s ownership structure has remained unchanged otherwise and continues to be controlled by Permira V GP Limited.
Permira acquired Dr Martens from the Griggs family in January 2014 for 300 million British pounds. Under its ownership, Dr Martens was listed on the London Stock Exchange at a value of 3.7 billion British Pounds in January 2021.
However, the company has come under scrutiny from shareholders in recent months following a series of disappointing financial results. In April, Dr. Martens issued its fifth profit warning in three years.
Image Credits: mosaic-lille.fr
Related news
Related Events
Related Organizations
-
-
Footwear Consumer 2030
A study reflecting on the main global consumer trends and the key changes for the footwear industry.
-
World Footwear Public Calendar
Click here to subscribe an updated version of the calendar displaying the footwear trade shows.
-
-
-
Media Partners
Media Partners
-
ARS ARPEL
SHOES-MAGAZINE.COM
UNIT Publishing House
Revista del Calzado